vs

Side-by-side financial comparison of FARMERS & MERCHANTS BANCORP INC (FMAO) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $32.5M, roughly 1.4× FARMERS & MERCHANTS BANCORP INC). FARMERS & MERCHANTS BANCORP INC runs the higher net margin — 30.2% vs -90.4%, a 120.6% gap on every dollar of revenue. On growth, FARMERS & MERCHANTS BANCORP INC posted the faster year-over-year revenue change (21.0% vs 13.8%). FARMERS & MERCHANTS BANCORP INC produced more free cash flow last quarter ($35.0M vs $-19.9M). Over the past eight quarters, FARMERS & MERCHANTS BANCORP INC's revenue compounded faster (16.1% CAGR vs 7.3%).

Rainier Bancorporation was the Seattle-based parent corporation of Rainier National Bank, a Washington state bank with branches throughout the state. Rainier traced its roots back to the National Bank of Commerce, which was founded by Richard Holyoke in 1889. The name Rainier National Bank was adopted in 1974. Rainier Bancorp expanded into Alaska with the purchase of Anchorage's People's Bank & Trust in 1983 and into Oregon with the purchase of Gresham's Mount Hood Security Bank in 1986, expa...

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

FMAO vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.4× larger
PACB
$44.6M
$32.5M
FMAO
Growing faster (revenue YoY)
FMAO
FMAO
+7.1% gap
FMAO
21.0%
13.8%
PACB
Higher net margin
FMAO
FMAO
120.6% more per $
FMAO
30.2%
-90.4%
PACB
More free cash flow
FMAO
FMAO
$54.9M more FCF
FMAO
$35.0M
$-19.9M
PACB
Faster 2-yr revenue CAGR
FMAO
FMAO
Annualised
FMAO
16.1%
7.3%
PACB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FMAO
FMAO
PACB
PACB
Revenue
$32.5M
$44.6M
Net Profit
$9.8M
$-40.4M
Gross Margin
37.1%
Operating Margin
39.5%
-92.3%
Net Margin
30.2%
-90.4%
Revenue YoY
21.0%
13.8%
Net Profit YoY
16.8%
-1802.7%
EPS (diluted)
$0.72
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FMAO
FMAO
PACB
PACB
Q4 25
$32.5M
$44.6M
Q3 25
$31.3M
$38.4M
Q2 25
$29.6M
$39.8M
Q1 25
$28.1M
$37.2M
Q4 24
$26.8M
$39.2M
Q3 24
$25.5M
$40.0M
Q2 24
$25.1M
$36.0M
Q1 24
$24.1M
$38.8M
Net Profit
FMAO
FMAO
PACB
PACB
Q4 25
$9.8M
$-40.4M
Q3 25
$8.9M
$-38.0M
Q2 25
$7.7M
$-41.9M
Q1 25
$7.0M
$-426.1M
Q4 24
$8.4M
$2.4M
Q3 24
$6.5M
$-60.7M
Q2 24
$5.7M
$-173.3M
Q1 24
$5.4M
$-78.2M
Gross Margin
FMAO
FMAO
PACB
PACB
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
FMAO
FMAO
PACB
PACB
Q4 25
39.5%
-92.3%
Q3 25
35.9%
-101.1%
Q2 25
32.7%
-112.8%
Q1 25
31.2%
-1154.5%
Q4 24
39.2%
-390.1%
Q3 24
31.7%
-160.3%
Q2 24
28.5%
-488.3%
Q1 24
28.2%
-209.6%
Net Margin
FMAO
FMAO
PACB
PACB
Q4 25
30.2%
-90.4%
Q3 25
28.3%
-98.9%
Q2 25
26.0%
-105.4%
Q1 25
24.8%
-1146.8%
Q4 24
31.2%
6.0%
Q3 24
25.5%
-151.9%
Q2 24
22.6%
-481.3%
Q1 24
22.3%
-201.4%
EPS (diluted)
FMAO
FMAO
PACB
PACB
Q4 25
$0.72
$-0.11
Q3 25
$0.64
$-0.13
Q2 25
$0.56
$-0.14
Q1 25
$0.51
$-1.44
Q4 24
$0.61
$-0.44
Q3 24
$0.48
$-0.22
Q2 24
$0.42
$-0.64
Q1 24
$0.39
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FMAO
FMAO
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$370.9M
$5.3M
Total Assets
$3.4B
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FMAO
FMAO
PACB
PACB
Q4 25
$279.5M
Q3 25
$298.7M
Q2 25
$314.7M
Q1 25
$343.1M
Q4 24
$389.9M
Q3 24
$471.1M
Q2 24
$509.8M
Q1 24
$561.9M
Stockholders' Equity
FMAO
FMAO
PACB
PACB
Q4 25
$370.9M
$5.3M
Q3 25
$361.8M
$36.1M
Q2 25
$350.8M
$61.5M
Q1 25
$344.6M
$91.6M
Q4 24
$335.2M
$506.6M
Q3 24
$335.4M
$453.1M
Q2 24
$322.7M
$492.7M
Q1 24
$317.7M
$649.0M
Total Assets
FMAO
FMAO
PACB
PACB
Q4 25
$3.4B
$784.1M
Q3 25
$3.4B
$803.2M
Q2 25
$3.3B
$825.5M
Q1 25
$3.4B
$860.8M
Q4 24
$3.4B
$1.3B
Q3 24
$3.4B
$1.5B
Q2 24
$3.3B
$1.5B
Q1 24
$3.3B
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FMAO
FMAO
PACB
PACB
Operating Cash FlowLast quarter
$36.7M
$-19.1M
Free Cash FlowOCF − Capex
$35.0M
$-19.9M
FCF MarginFCF / Revenue
107.8%
-44.6%
Capex IntensityCapex / Revenue
5.4%
1.9%
Cash ConversionOCF / Net Profit
3.75×
TTM Free Cash FlowTrailing 4 quarters
$56.7M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FMAO
FMAO
PACB
PACB
Q4 25
$36.7M
$-19.1M
Q3 25
$11.2M
$-18.7M
Q2 25
$1.1M
$-29.4M
Q1 25
$11.0M
$-44.1M
Q4 24
$32.5M
$-30.6M
Q3 24
$18.7M
$-45.5M
Q2 24
$9.7M
$-54.3M
Q1 24
$1.5M
$-75.7M
Free Cash Flow
FMAO
FMAO
PACB
PACB
Q4 25
$35.0M
$-19.9M
Q3 25
$10.7M
$-18.8M
Q2 25
$385.0K
$-29.9M
Q1 25
$10.6M
$-45.4M
Q4 24
$30.6M
$-32.3M
Q3 24
$18.3M
$-46.3M
Q2 24
$9.2M
$-55.7M
Q1 24
$1.3M
$-79.6M
FCF Margin
FMAO
FMAO
PACB
PACB
Q4 25
107.8%
-44.6%
Q3 25
34.3%
-48.9%
Q2 25
1.3%
-75.3%
Q1 25
37.8%
-122.3%
Q4 24
114.1%
-82.3%
Q3 24
71.7%
-115.7%
Q2 24
36.5%
-154.8%
Q1 24
5.3%
-205.0%
Capex Intensity
FMAO
FMAO
PACB
PACB
Q4 25
5.4%
1.9%
Q3 25
1.5%
0.2%
Q2 25
2.4%
1.4%
Q1 25
1.4%
3.7%
Q4 24
7.0%
4.1%
Q3 24
1.4%
2.0%
Q2 24
2.3%
4.1%
Q1 24
0.9%
10.0%
Cash Conversion
FMAO
FMAO
PACB
PACB
Q4 25
3.75×
Q3 25
1.26×
Q2 25
0.14×
Q1 25
1.58×
Q4 24
3.87×
-12.93×
Q3 24
2.86×
Q2 24
1.71×
Q1 24
0.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FMAO
FMAO

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons